Anti-PD1/TROP2 bispecific antibody (Xiamen University)

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameAnti-PD1/TROP2 bispecific antibody (Xiamen University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-PD-1Anti-Trop-2
TargetsProgrammed cell death protein 1Tumor-associated calcium signal transducer 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXiamen University
China Registration ClassN/A

Develop Information

Active CompaniesXiamen University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A